Pharmaceutical Care Network Europe

The Pharmaceutical Care Network Europe (PCNE) was established in 1994  and it became an official association (under Dutch law) in 2004.
Pharmaceutical Care is the pharmacist's contribution to the care of individuals, in order to optimize medicines use and improve health outcomes.

Conferences Working groups

9th PCNE Working Symposium 2024 , University of Basel, Switzerland

Advancing the paradigm and visibility of pharmacy practice research

20 - 22 June 2024


Advancing the paradigm and visibility of pharmacy practice research

Basel 20 -22 June 2024

A key topic will be the Granada Statements that were recently published simultaneously in 12 journals. How can researchers contribute to strengthening the reporting of pharmacy practice as a discipline? Shane Desselle, co-author and editor-in-chief at Elsevier will shape an answer.
During workshops, participants will be invited to reflect on their own research and share their experience.

We will have much to celebrate with the 30th anniversary of the PCNE association that was founded in 1994 AND the 20th anniversary of the pharmacists’ reference journal Research in Social and Administrative Pharmacy (RSAP) that was launched in 2004. Don’t miss our social event with the boat trip and the dinner on the Rhine!

To plan your attendance to PCNE symposium 2024, we have compiled some Practical information to prepare your venue to PCNE symposium @Basel 20-22 June 2024

Registration is open.

For any questions: info@pcne.org

 

The organisation of the symposium is supported by pharmaSuisse, the Swiss association of pharmacists; the journal Research in Social and Administrative Pharmacy (RSAP), the State Chancellery of City of Basel; TopPharm, the grouping of independent community pharmacies; OFAC the professional cooperative society of Swiss pharmacists;  Tillots Pharma AG, BWT Best Water / Reusable tritan water bottle

Gold

Sponsor

SAV Logo rgb DE ps (2)

RSAP logo

Silver

Sponsor

 logo staatskanzlei basel  

 

Bronze

Sponsor

 tp apotheken cmyk.jpeg  logo ofac horizontal de RVB  Logo Tillotts Pharma BWT Logo neu cmyk

 

Foppe van Mil Memorial Lecture (Keynote lecture 1):

Friday 21 June 2024. 09:00 - 09:45

Pharmacist-led/Pharmaceutical Care to Improve Outcomes of Patients With Cardiovascular Diseases

Prof. Martin Schulz, RPh, PhD, FFIP, FESCP, Managing Director, Department of Medicine, ABDA, Germany

Cardiovascular diseases (CVD) are the number one cause of death globally. CVD are often accompanied with comorbidities and, therefore, with multiple drug regimens. Drug-related morbidity and mortality due to drug-related problems represent a serious problem in these patients. The evidence for pharmacist-led/pharmaceutical care in hypertension, CVD risk reduction and, at least in part, in chronic heart failure, dyslipidemia, and diabetes is compelling. However, unmet needs in CVD e.g., (primary) medication non-adherence, guideline inertia (lack of implementation of and persistence to evidence-based pharmacotherapy), or uncontrolled blood pressure persist. On the other hand, and apart from widespread implementation of clinical pharmacy services in daily routine, both precision and population approaches are required and need further evaluation.

 Martin Schulz  Portrait(1)

 

 

 

Keynote lecture 2:

Friday 21 June 2024. 14:00 - 14:45

The Granada statements 2022

 

Prof. Shane P. Desselle, RPh, PhD, FAPhA, Touro University California; Editor, Research in Social and Administrative Pharmacy

The study of disciplinary progress is a fascinating one; that is, the extent to and rate at which disciplines or areas/fields of study advance their scientific paradigm. Scientific paradigm can be expressed as the degree to which its constituent scholars agree on the primary areas of research to inquire, the most appropriate methods and best practices by which to conduct the research, and the most salient issues to teach students (future practitioners) in the field. The concept of scientific paradigm anchored a meeting of editors that produced the Granada Statements, co-published in a dozen international journals in pharmacy practice/social pharmacy. The “Granada Group” of journals has tossed aside ideas of competition and instead, embraced collaboration. The Granada Statements identified key actions for readers, researchers, editors, publishers, and various decision-makers to advance the scientific paradigm of pharmacy practice.  

Shane Desselle

 

 

 

Keynote lecture 3:

Saturday  22 June 2024. 11:15 - 12:00

Healthcare data: the new goldmine

Prof. Eric van Ganse, MD, PhD, FRCP; Epidemiologist; Claude-Bernard University , Lyon (France)

Over the last decades, many healthcare data (HCD) have been largely digitalized, from General Practitioners Records to Community Pharmacists Dispensations. As a rule, digitalization started « bottom up », typically initiated by local groups of HCPs in interaction with IT companies. Nowadays, often as a result of « Payors » initiatives, healthcare data are linked at patients’ level, and histories of longitudinal care of large populations become available for research. We shall discuss general attributes of healthcare datasets (pros and cons) and some recent developments, focussing on the role that community pharmacists could play in enriching HCD.

 Eric v Ganse IMG 3513.JPG

 

Workshop 1 & 6: Cultivating Cohesian: Building a strong research team

Workshop Facilitators: 

  • Rhonda Clifford, Perth, University of Western Australia
  • Liza Seubert, Perth University of Western Australia
  • Julie Loveny, Perth, University of Western Australia

We invite you to a transformative workshop that combines real-world research insights with practical strategies for forming an exceptional team. In this hands-on workshop you’ll apply insights from research of the UWA Pharmacy team directly to your own team-building strategy. This process will provide a strong foundation to foster a strong cohesive team that can tackle complex challenges.

Rhonda Clifford  Lisa Seubert  Julie Prof headshot

 

Workshop 2 & 7: From Guidelines to Quality Indicators: Pharmaceutical Care for Diabetes Type 2 in a Global Context

 

Workshop Facilitators:

  • Dr. Kenji Fujita, The University of Sydney, Kolling Institute, Australia
  • Dr. Kjell Halvorson, UiT The Arctic University of Norway, Norway
  • Dr. Martina Teichert, Leiden University, Netherlands

The PCNE working group on Guidelines & Indicators has developed and published a definition of Quality Indicators for Pharmaceutical Care. (PhC). (Fujita K. et al, 2023) Subsequently,

the working group has completed extracting national guideline recommendations for pharmaceutical care to Diabetes Type 2 patients (DM2) from >10 countries, aiming for the development of a ‘core set’ of quality indicators (QIs) for DM2 in community pharmacies in these countries. In this stage, those recommendations need to be translated into QIs.

 

Learning objectives

After this workshop the participants will be able to:

  • explain the definition of QIs for PhC and their development process
  • translate guideline recommendations into QIs
  • get insight into the measurement properties of QIs and the validation process

Activities

During the workshop the participants will:

  • understand the achievements of this working group and the ongoing project
  • be involved in the translation of guideline recommendations into QIs
  • discuss the timing for assessing each measurement property of potential QIs, such as feasibility and applicability. This discussion will consider whether these properties should be assessed during an expert panel or a pilot study based on the participants' experience and knowledge across different countries.

Targeted workshop participants

This workshop is open to anyone, including higher degree research students, who are interested in measuring and improving quality of care can join in this workshop. After the workshop, participants will have the opportunity to join our working group.

 Kenji Fujita

 Teichert

 Kjell H. Halvorsen.JPG

Workshop 3 & 8: Beyond Version 9.1: Shaping the Future of PCNE DRP Classification

 

Workshop Facilitators: 

  • Tommy Westerlund, Sweden
  • Ina Richling, Germany
  • Nejc Horvat, Slovenia

Description and aim:

Over the past few years, several validation studies have been conducted on the PCNE DRP classification, leading to the evolution of the classification from version 7 to the current version 9.1. Throughout these studies, numerous proposals for classification changes were put forward. These recommendations will be presented, deliberated upon, and subject to a vote. The objective is to enhance the classification in accordance with agreed-upon improvements, ultimately leading to the development of either v9.2 or v10.

 Ina Richling v2 nejc horvat 2  Tommy Westerlund Aug 2023.jpeg

Workshop 4 & 9: Adherence: Before the start of the study - Training community pharmacists who will recruit patients and defining the minimal core set of collected data

 

Workshop Facilitators: 

  •  PD Dr. Isabelle Arnet, University Basel, Switzerland
  •  Dr. Christiane Eickhoff, ABDA, Germany

The 15-STARS questionnaire has been developed to screen for adherence difficulties in ambulatory patients. It tackles modifiable determinants. When planning a study with community pharmacists who will use the 15-STARS, investigators need to train the pharmacists who will recruit the patients and collect the data. In this workshop, we will delineate the major elements that need to be ready before the study can start.

 

We will:

  • recap the purpose and the use of the 15-STARS questionnaire,
  • define the material needed to train the pharmacists who will run the study,
  • define the minimal data to collect that will enable a pooling of results from several countries.

 Participation to prior workshops is not needed.

 Portrait Isabelle2023

Portrait Christiane

 

Workshop 5 & 10: Artificial Intelligence and Machine Learning in Pharmaceutical Care Research and Practice

 

Workshop Facilitators:

  • Prof. Kreshnik Hoti, Kosovo
  • Prof. Mitja Kos, Slovenia

This is an educational workshop.  

 

Background

This workshop is your gateway to understanding how artificial intelligence and machine learning can drive improvements in patient safety and effective healthcare services delivery. It is about innovating pharmaceutical care practices to meet the demands of our evolving world. We recognize the importance of demystifying these technologies and making them accessible, not just to data scientists and technologists, but to healthcare professionals, researchers, and practitioners.

 

The aim of the workshop is:

  • To provide a foundational understanding of artificial intelligence in healthcare research and practice.
  • To engage participants in a hands-on experience in machine learning.
  • To discuss practical applications of machine learning in pharmaceutical care practice.

Learning objectives:

  • To understand the potential and functions of artificial intelligence.
  • To acquire the ability to employ fundamental machine learning techniques.

Activities in the workshop:

  • Activity 1: Introduction to AI in Healthcare (Presentation and Discussion): Participants will be introduced into the fundamental concepts and principles of artificial intelligence, key components, and its developing role in healthcare research and practice.
  • Activity 2: Hands-on Machine Learning (Practical Exercise): Through interactive activities and discussions, we will engage you in a hands-on experience with machine learning, providing the practical skills you need to harness the power of data-driven decision-making.
  • Activity 3: Discussion on machine learning applications in Pharmaceutical Care (Group Discussion):Participants will be asked to brainstorm and discuss potential applications of machine learning in a series of case studies to get an insight into the transformative impact these technologies can have on patient care.

  Kreshnik Hoti 2

 MK

 

 

Expert courses - Program Thursday 20th June 2024

12.00-13.00

Registration

Biozentrum Hall U1

13.00-17.00

Expert course 1: “I have data to publish – How to proceed and choose the appropriate journal?” Ema Paulino (Portugal) + Filipa da Costa (Portugal)

Room U1-195

13.00-17.00

Expert course 2:  The Granada statements 2022 – What does this mean to my research?
Shane Desselle (USA)

Room U1.193

13.00-17.00

Expert Course 3: How to submit a successful grant?
Jacqueline Hugtenburg (Netherlands) + Mara Guerreiro (Portugal)

Room U1.191

15.00-17.00

Parallel mini symposium: PCN-Switzerland “smarter medicine” – in German

(Separate registration: www.pcn-s.ch)

Lecture Room 

Kollegiengebäude Petersplatz 1,       Room 115

17.30-19.00

Welcoming ceremony incl. food and drinks, networking with Newcomers

Participants of PCN-Switzerland joining

Wildt’sches Haus

Symposium - Program Friday 21th June 2024

8.00

Registration

Biozentrum Hall U1

8.30-9.00

Opening

Lecture Room U1.131

9.00-9.45

Foppe van Mil lecture - Martin Schulz (Germany)

Lecture Room U1.131

9.45-10.00

Coffee break + transfer to the WS rooms

Hall U1                      

10.00-13.00

WS1: Cultivating cohesion: Building a strong research team -

Ronda Clifford, Liza Seubert, Julie Loveny (Australia)

Room 01.004

10.00-13.00

WS2: Training community pharmacists who will recruit patients and defining the minimal core set of collected data - Isabelle Arnet (Switzerland), Christiane Eickhoff (Germany)

Room U1.197

10.00-13.00

WS3: Beyond version 9.1: Shaping the future of PCNE DRP classification -

Tommy Westerlund (Sweden), Ina Richling (Germany), Nejc Horvat (Slovenia)

Room U1.195

10.00-13.00

WS4: From guideline to quality indicators – Pharmaceutical Care for diabetes 2 in a global context - Martina Teichert (Netherlands), Kenji Fujita (Australia), K Halvorsen (Norway)

Room U1.193

10.00-13.00

WS5: Artificial intelligence and Machine learning in Pharmaceutical Care research and practice - Mitja Kos (Slovenia), Kreshnik Hoti (Kosovo)

Room U1.191

13.00-14.00

Lunch


PCNE Soapbox (members only) incl. lunch 

Hall U1

Room 01.004

14.00-14.45

Keynote lecture 2 – Shane Desselle and the Granada statements 2022

Lecture Room U1.131

15.00-16.00

Poster walking tour

Hall U1 / O1 / O2

16.00-16.15

Coffee break

Hall U1

16.15-17.15

Oral communications 1-6 (8 min each)

Lecture Room U1.131

17.30-20.00

PCNE General Assembly (members only)

Lecture Room U1.131

20.00-23.00

PCNE Networking event (separate registration) + 20th anniversary RSAP

Rhine boat   

Symposium - Program Saturday 22th June 2024

     

08.00-11.00

WS1: Cultivating cohesion: Building a strong research team -

Ronda Clifford, Liza Seubert, Julie Loveny, Australia

Room U1-197          

08.00-11.00

WS2: Training community pharmacists who will recruit patients and defining the minimal core set of collected data - Isabelle Arnet (Switzerland), Christiane Eickhoff (Germany)

Room U1.195

08.00-11.00

WS3: Beyond version 9.1: Shaping the future of PCNE DRP classification - Cancelled

 

08.00-11.00

WS4: From guideline to quality indicators – Pharmaceutical Care for diabetes 2 in a global context - Martina Teichert (Netherlands), Kenji Fujita (Australia), K Halvorsen (Norway)

Room U1.193

08.00-11.00

WS5: Artificial intelligence and Machine learning in Pharmaceutical Care research and practice - Mitja Kos (Slovenia), Kreshnik Hoti (Kosovo)

Room U1.191

11.00-11.15

Coffee break + transfer to lecture hall

Hall U1

11.15-12.00

Keynote Lecture 3 –Eric van Ganse (CHU Lyon)

Lecture Room U1.131

12.00-13.00

Closing session, incl. awards for poster and oral

Lecture Room U1.131

13.00-14.00

Lunch bag and bye bye

Hall U1

 

Abstract submission will be closed on 19th April 2024

Abstracts must preferably liaise with the themes of PCNE or the Symposium: Advancing the paradigm and visibility of
pharmacy practice research

For submission of abstracts the following sections are needed: Title, Background, Purpose, Method, Findings, and Conclusion.

Please respect the guideline for abstract submission and especially the maximum length of 400 words.

 

The poster presentation with the highest quality as per the evaluation of the Scientific Committee will be selected for                                   the PCNE poster award, sponsored by PCNE.

The abstracts with the highest quality as per the evaluation of the Scientific Committee will be selected to be presented at the Oral Communications session with an award for the best oral communication sponsored by FI (Förderinitiative Pharmazeutische Betreuung; www.foerderinitiative.de). FI Logo2011 RGB

 

All accepted abstracts will be published in the Journal "Research in Social and Administrative Pharmacy (RSAP). RSAP logo

 

 

 

List of accepted abstracts (click on the title to see the abstract)

ID Title Scope Organization
667 Feasibility of the 15-STARS questionnaire for medication adherence optimization in community pharmacies: the Lithuanian pharmacists’ perspectives Adherence Vilnius University
671 Are determinants captured by the 15-STARS questionnaire suitable to develop adherence-enhancing interventions in inflammatory bowel disease patients? Adherence Department of Pharmaceutical Sciences, University of Basel, Switzerland
674 Translation and cultural adaptation of the “15-STARS” questionnaire into Spanish Adherence Clinical Pharmacy and Pharmaceutical Care Unit, Department of Pharmacy and Pharmaceutical Technology, and Physical Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Spain
677 Prescribing patterns of proton pump inhibitors in patients with lung cancer treated with immunotherapy Adherence University of Ljubljana, Faculty of Pharmacy
687 Stakeholders’ views on reasons for poor adherence to rectal dosage forms in ulcerative colitis Adherence Pharmacaeutical Care Research Group
697 Adherence Strategies for Polypharmacy in Epilepsy: A Case Report Utilizing Electronic Monitoring Adherence Pharmaceutical Care Research Group, Dept. Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland
698 Translation and adaptation of the MIS-A (Medication Intake Survey-Asthma) questionnaire in Macedonian language Adherence Faculty of Medical Sciences, Goce Delcev University, Stip, Krste Misirkov Str., No. 10-A, P.O. Box 201, 2000 Stip, North Macedonia
716 The New Medicines Service across borders - Lessons learnt from 14 years of implementation attempts. Adherence School of Pharmaceutical Sciences, Faculty of Science, University of Geneva, Switzerland
717 Understanding context for adapting the New Medicine Service for Switzerland using a convergent mixed methods design – myCare Start-I Adherence School of Pharmaceutical Sciences, Faculty of Science, University of Geneva, Switzerland
672 External validation of an assessment tool for drug-related hospitalisations in a general emergency department population Drug-related Problems Diakonhjemmet Hospital Pharmacy, Oslo, Norway
675 Diabetes and osteoporosis: most common negative disorders resulting from Drug-Related Problems of the most used pharmacotherapeutic groups Drug-related Problems 1 Muy Ilustre Colegio Oficial de Farmacéuticos de Valencia (MICOF). Valencia, Spain.
680 Assessing the Effectiveness of Commonwealth Partnerships for Antimicrobial Stewardship to Tackle Antimicrobial Resistance Drug-related Problems Commonwealth Pharmacists Association, London, United Kingdom
682 Evaluating the implementation and effectiveness of a hub and spoke model to deliver antimicrobial stewardship interventions in Africa Drug-related Problems Commonwealth Pharmacists Association, London, United Kingdom
683 Assessing the Impact and Lessons Learned from Surveillance and Prescribing Support for Antimicrobial Stewardship in Africa and Asia: A Mixed Methods Evaluation Drug-related Problems Commonwealth Pharmacists Association, London, United Kingdom
692 Exploring Discrepancy Classification: A Scoping Review of Pharmacy Students' Practices in Obtaining Best Possible Medication Histories Drug-related Problems University of Innsbruck, Department of Clinical Pharmacy
693 Drug-related problems during hospital-to-home transitions – first pharmacists´ perceptions of routine care Drug-related Problems Pharmacy Department, Universitätsklinikum Erlangen and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
726 Pain management with analgesics in hospitalized patients with renal impairment: a focus on potential inappropriate medication use and rehospitalization risk Drug-related Problems University of Prishtina, Faculty of Medicine, Division of Pharmacy, Department of Pharmacy Practice and Pharmaceutical Care, Prishtina, Kosovo
732 Which prescribing cascades are relevant for clinical practice? A mixed-method study Drug-related Problems University of Groningen, UMCG, Groningen, The Netherlands
650 Multistakeholder perspectives on ensuring quality in professional community pharmacy services: insights from nominal group discussions in England Indicators and Guidelines The University of Manchester
663 Regional differences of the impact of COVID-19 pandemic on cancer diagnosis rate in Portugal Indicators and Guidelines University of Porto
673 Exploring clinical and social pharmacy researchers’ perspectives on the Granada Statements Indicators and Guidelines Department of Pharmacology, Faculty of Pharmacy, Başkent University, 06790 Etimesgut, Ankara, Türkiye
699 Slovenian Clinical Guideline Development: Insights and Implications Indicators and Guidelines University of Ljubljana, Faculty of Pharmacy
700 Evaluating the education provided by community pharmacists to municipal staff about medication handling using recently developed quality indicators Indicators and Guidelines Danish College of Pharmacy Practice—Pharmakon
709 Professional Pharmacy Services' Outcomes Measurement: A Narrative Review Indicators and Guidelines CBIOS – Universidade Lusófona’s Research Center for Biosciences & Health Technologies, Campo Grande 376, 1749-024 Lisboa, Portugal
654 New tools for medication review: Drug-Related Problems solved by Revisem® in polymedicated elderly patients at rural pharmacies. Medication Review 4 Departamento de Historia de la Ciencia y Documentación. Universidad de Valencia (UV). Valencia. Spain. 5 UISYS-Unidad asociada al Instituto Interuniversitario de Investigación Avanzada sobre Evaluación de la Ciencia y la Universidad (INAECU). UC3M-UAM3. Madrid, Spain. 6 CIBERONC. Valencia, Spain.
669 The interprofessional medication management programme ARMIN: Patients’ expectations and needs from the pharmacist perspective Medication Review 1 Department of Medicine, ABDA—Federal Union of German Associations of Pharmacists, Berlin, Germany
690 Primary care pharmacist-led medication review in older adult patients with potentially inappropriate prescriptions. Medication Review EDP Salut Sant Joan de Reus-Baix Camp
706 What benefits do patients expect of community pharmacist-led medication reviews? A cross-sectional survey Medication Review Internal Medicine IX – Department of Clinical Pharmacology and Pharmacoepidemiology Heidelberg University Hospital – Medical Clinic (Krehl-Klinik), Im Neuenheimer Feld 410, 69120 Heidelberg, Germany.
708 Towards a proficiency test system for medication reviews with virtual patients in German community pharmacies Medication Review Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn, Bonn, Germany
713 Evaluation of a medication use review service in Swiss community pharmacies: preliminary results from initial patients’ consultations Medication Review Center for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland
651 Cancer survivors’ perspective on and input for a community pharmacy-based intervention for managing late effects of cancer (LEC) Research in Pharmaceutical Care University of Copenhagen
652 Content, pros and cons of counselling at on-line pharmacy only Research in Pharmaceutical Care University of Copenhagen
653 Burnout and Competency Development Among Community Pharmacists: Exploring Patterns Research in Pharmaceutical Care University of Belgrade - Faculty of Pharmacy, Serbia
655 Pharmacy students’ learning of real patients in a simple first-person perspective patient simulation exercise — A qualitative analysis Research in Pharmaceutical Care University of Copenhagen
656 Making patients feel understood at the pharmacy counter - the act of communicating based on heightened awareness of emotional states Research in Pharmaceutical Care University of Copenhagen
657 Psychometric validation of the Danish translation of the Measure of Job Satisfaction (MJS) for pharmacy staff Research in Pharmaceutical Care University of Copenhagen
658 Job satisfaction among Danish pharmacy staff – a questionnaire survey Research in Pharmaceutical Care University of Copenhagen
659 Pharmacist prescribing in primary care: a Dutch citizen perspective Research in Pharmaceutical Care Nivel, Netherlands Institute for Health Services Research
660 Pharmacist perspective on the potential introduction of pharmacist prescribing – a nationwide survey study Research in Pharmaceutical Care Utrecht University
661 Integrating Community Pharmacy into Primary Care: A Qualitative Study in the Basque Country (Spain) Research in Pharmaceutical Care Pharmacy Practice Research Group, University of the Basque Country UPV/EHU
662 Research Protocol for Integration between Community Pharmacy and Primary Care in the Basque Country (Spain) Research in Pharmaceutical Care Pharmacy Practice Research Group, University of the Basque Country UPV/EHU
664 Stakeholder Perspectives on Integrating Community Pharmacy into Primary Health Care: A Qualitative Study Research in Pharmaceutical Care Pharmaceutical Care Research Group, University of Granada, Granada, Spain.
665 Development of a Temporal Model for the Integration of Community Pharmacy and Primary Care: A Stakeholder-Driven Approach Research in Pharmaceutical Care Pharmaceutical Care Research Group, University of Granada, Granada, Spain.
666 “This was 2000 times better than math” – The Enduring Impact of a Community Pharmacist-led Theme Day on Medication Knowledge Among Primary School Students Research in Pharmaceutical Care University of Copenhagen
668 Could a question prompt list activate patients in community pharmacy? A feasibility study Research in Pharmaceutical Care University of Gothenburg
670 Medication discrepancies revealed by medication reconciliation after hospital discharge in patients with multiple long-term conditions Research in Pharmaceutical Care Department of Pharmacy, Section for Pharmacology and Pharmaceutical Biosciences, University of Oslo, Oslo, Norway
676 HOW MUCH MEDICAL AND PHARMACEUTICAL KNOWLEDGE WILL GERMAN NURSES NEED IN THE FUTURE? Research in Pharmaceutical Care Faculty of Health, University of Applied Sciences and Arts, Bielefeld, Germany
679 Pharmacist Perspectives on Assisted Suicide: Unveiling Challenges & Improving Pharmaceutical Care (the PAS-Study) Research in Pharmaceutical Care Institute of Pharmacy, Pharmaceutical Biology & Clinical Pharmacy, Paracelsus Medical University, Strubergasse 21, Salzburg, 5020, Austria
681 Drug shortages: reasons, extent and implications: a multifaceted survey Research in Pharmaceutical Care Paracelsus Medical University, Salzburg, Austria
684 Challenges Faced by Pharmacists in 2023 Türkiye Earthquakes Research in Pharmaceutical Care Department of Pharmacy Management, Faculty of Gülhane Pharmacy, Sağlık Bilimleri University, Ankara, Türkiye
685 Balancing Research and Practice Contributions in Pharmacy Faculty Performance Evaluations: A Narrative Review Research in Pharmaceutical Care University of Minnesota College of Pharmacy
686 PRELIMINARY RESULTS OF THE ONGOING MYCARE START STUDY IN EARLY ADOPTERS’ SWISS COMMUNITY PHARMACIES Research in Pharmaceutical Care Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
688 Performance of the Medication Adherence Universal Questionnaire (MAUQ) in patients under oral antineoplastic medication Research in Pharmaceutical Care ULS Alto Ave
689 Medication Errors in Community Pharmacies: A Systematic Review of the International Literature Research in Pharmaceutical Care School of Pharmacy, Newcastle University, Newcastle upon Tyne, United Kingdom, School of Pharmacy, King Khalid University, Abha, Saudi Arabia
691 How common is medication-related burden in adults with long-term therapies – a population survey using an instrument based on the PLEM model Research in Pharmaceutical Care School of Pharmacy, University of Eastern Finland
694 Barriers and facilitators to the recruitment of Swiss community pharmacies for an app-driven adherence service Research in Pharmaceutical Care Pharmaceutical Care Research Group, University of Basel
695 Digital Counselling Support Tool to Enhance Evidence-Based Pharmacy Practice Research in Pharmaceutical Care University of Basel
696 Association between indexing methods and Medical Subject Headings (MeSH) attributed to research articles Research in Pharmaceutical Care University of Porto
701 Swedish pharmacists’ attitudes to pharmacist prescribing Research in Pharmaceutical Care Uppsala University
702 Contextual analysis to find implementation strategies for an interprofessional process to improve medication safety in primary care – the P3S study Research in Pharmaceutical Care Pharmaceutical Care Research Group University of Basel
703 Do clinicians have preferences while prescribing DOAC to AF-patients after a stroke? A secondary data analysis of the MAASTRO-study in Basel, Switzerland Research in Pharmaceutical Care Department of Pharmaceutical Sciences, Pharmaceutical Care Research Group, University of Basel
704 Application of a Human Factors and Systems Engineering Approach to Explore the Hospital to Home transition for patients with multiple long-term conditions. Research in Pharmaceutical Care Section for Pharmacology and Pharmaceutical Biosciences, University of Oslo, Oslo, Norway
705 An assessment of the knowledge of Substandard and Falsified Medicines as a baseline for building capacity and capability among health care workers in eight African countries. Research in Pharmaceutical Care Commonwealth Pharmacists Association
707 A comprehensive training program on patient-centered tasks for hospital-based clinical pharmacists. Research in Pharmaceutical Care Department of Pharmacy, University of Oslo, Norway / Oslo Hospital Pharmacy, Hospital Pharmacies Enterprise, South Eastern Norway
711 From screening and a pharmaceutical care intervention to follow-up calls – how can we effectively solve patients’ difficulties in handling their medication in the inpatient setting? Research in Pharmaceutical Care Heidelberg University, Medical Faculty Heidelberg / Heidelberg University Hospital, Medical Clinic (Krehl-Klinik), Internal Medicine IX - Department of Clinical Pharmacology and Pharmacoepidemiology, Cooperation Unit Clinical Pharmacy, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany
712 Malnutrition and adherence to Oral Nutritional Supplements: a pilot support programme in Portuguese community pharmacies Research in Pharmaceutical Care Ezfy, Portugal
714 Pharmacist prescribing – perspective of German community pharmacists Research in Pharmaceutical Care Faculty of Health, University of Applied Sciences and Arts, Bielefeld, Germany
715 Evaluation of the Community Pharmacy Quality Scheme (PQS) in England: Evidences from stakeholder interviews Research in Pharmaceutical Care The University of Manchester
718 Role of Portuguese Community Pharmacies in Decreasing Distances and Impact on Influenza vaccination coverage Research in Pharmaceutical Care Centre for Health Evaluation & Research/Infosaúde, National Association of Pharmacies (CEFAR/IF, ANF), Lisbon, Portugal
719 Enhancing Healthcare Delivery: A Structured Approach for Common Ailment Management in Portuguese Community Pharmacies Research in Pharmaceutical Care Centre for Medicines Information and Health Interventions/Infosaúde, National Association of Pharmacies (CEDIME/IF, ANF), Lisbon, Portugal
720 Exploring community pharmacists’ practices and clinical reasoning after hospital discharge Research in Pharmaceutical Care nstitute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.
721 Determinants affecting the collaborative professional practice between community pharmacists and general practitioners in primary care in Spain. Research in Pharmaceutical Care Universidad de Granada
722 Evaluating performance of ChatGPT in answering pharmacist relicensing exam questions Research in Pharmaceutical Care University of Prishtina, Faculty of Medicine, Division of Pharmacy, Department of Pharmacy Practice and Pharmaceutical Care, Prishtina, Kosovo
723 Community pharmacies as clinical study centres: insights from the start-up phase of the VA|PREVENTION project Research in Pharmaceutical Care Ezfy, Lda
724 A Core Outcome Set for studies testing interventions to optimise medication use following hospital discharge - An international Delphi study Research in Pharmaceutical Care University of Oslo, Department of Pharmacy
725 Pharmacists' interpretation of laboratory test results as means of assisting their decision-making around medication related issues Research in Pharmaceutical Care University of Prishtina, Faculty of Medicine, Division of Pharmacy, Department of Practice and Pharmaceutical Care, Prishtina, Kosova
727 Challenges and opportunities at the interface between hospitals, outpatient care services/caregivers and community pharmacies (CAPAA)? A qualitative study Research in Pharmaceutical Care University of Applied Sciences Esslingen, Faculty Social Work, Education and Nursing
728 Barriers and facilitators to pain identification and effective analgesic use in infants within the community pharmacy setting: a qualitative study of parents’ perspectives. Research in Pharmaceutical Care University of Prishtina, Faculty of Medicine, Division of Pharmacy, Department of Pharmacy Practice and Pharmaceutical Care, Prishtina, Kosovo
729 Assessment of medication literacy of anticoagulation therapy in hospitalized orthopedic patients Research in Pharmaceutical Care Department of Social Pharmacy and Pharmaceutical Legislation, University of Belgrade-Faculty of Pharmacy, Belgrade, Serbia & Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University, Akademika Heyrovského 1203/8, Hradec Králové, Prague, Czech Republic
730 Prevalence of prescribing cascades in Danish hospitals Research in Pharmaceutical Care University of Copenhagen
731 Healthcare providers’ perspectives on antidepressant discontinuation: a focus group study Research in Pharmaceutical Care Amsterdam UMC

Expert Course 1: I have data to publish - How to proceed and choose the appropriate journal?

Moderators:

  • Ema Paulino (Portugal)
  • Filipa da Costa (Portugal)

Once a study has been conducted, it is time to inform the scientific community of the findings. Especially in the biomedical field, there are certain conventions for sharing the results. The selection of the publishing platform is an important step, as there are some factors to consider when choosing a journal (impact factor, audience, scope, etc.).

 

This expert course aims to empower researchers with the knowledge and tools necessary to navigate the complex process of publishing data effectively, and choosing the right journal to maximize the impact of your research.

 

Filipa da Costa2  Porztrait Ema2

 

 

Expert Course 2: The Granada statements 2022 - What does this mean to my research?

Moderator:   Shane P. Desselle, RPh, PhD, FAPhA (USA)

The study of disciplinary progress is a fascinating one; that is, the extent to and rate at which disciplines or areas/fields of study advance their scientific paradigm. Scientific paradigm can be expressed as the degree to which its constituent scholars agree on the primary areas of research to inquire, the most appropriate methods and best practices by which to conduct the research, and the most salient issues to teach students (future practitioners) in the field. The concept of scientific paradigm anchored a meeting of editors that produced the Granada Statements, co-published in a dozen international journals in pharmacy practice/social pharmacy.

The “Granada Group” of journals has tossed aside ideas of competition and instead, embraced collaboration. The Granada Statements identified key actions for readers, researchers, editors, publishers, and various decision-makers to advance the scientific paradigm of pharmacy practice.

Shane Desselle

This expert course will review what that means for prospective authors in regard to best practices, what the journals are looking for, what sort of practices and types/areas of research we are discouraging, in addition to identifying the collaborations between the Granada Group of journals that should make it clearer and potentially easier to publish in any one of our journals, more clearly demarcating the similarities and differences among the journals, and providing greater assistance to authors in any number of ways, whilst the Group works on additional endeavors such as a pharmacy practice research glossary.

Discover how each and every one of you can play a part in advancing the field and making our research more visible and salient to persons outside our field.

 

Expert Course 3: How to submit a successful grant

Moderators:

  • Jacqueline Hugtenburg (Netherlands)
  • Mara Guerreiro (Portugal)

Academics need the skills to write winning grant applications to conduct research sustainably and maximise the societal benefit of science. Writing a good grant application is challenging but is a skill that can be perfected.

Real life examples will be presented and practical exercises in small groups will be performed, drawing attention to key issues, such as how to meet eligibility criteria and guidelines of the funding body.

This course will be delivered by researchers with an established track record in leading successful grant applications and is intended to help those less experienced in grant writing, to increase their likelihood of being funded.

Mara Guerrero2 Jacqueline Hugtenburg agp